Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma

BMC Medical Genetics

Ali O Gure³  Nasser K Altorki⁵  Yao T Chen²  Ozlen Konu³  Murat Isbilen³  Zeynep Kalaylioglu¹  Ahmet R Barutcu⁴  Mithat Gonen⁶  Kerem M Senses³ 

[1] Department of Statistics, Middle East Technical University, Ankara, Turkey;Department of Pathology, Weill Medical College of Cornell University, New York, NY, USA;Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey;Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA, USA;Department of Cardiothoracic Surgery, Weill Medical College of Cornell University, New York, NY, USA;Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

关键词: DNA methylation;    Adomet;    1-carbon pathway;    Cancer-testis genes;   

Others  :  1122626
DOI  :  10.1186/1471-2350-14-97

 received in 2013-04-17, accepted in 2013-09-20,  发布年份 2013

【 摘 要 】

Background

Tumor-specific, coordinate expression of cancer-testis (CT) genes, mapping to the X chromosome, is observed in more than 60% of non-small cell lung cancer (NSCLC) patients. Although CT gene expression has been unequivocally related to DNA demethylation of promoter regions, the underlying mechanism leading to loss of promoter methylation remains elusive. Polymorphisms of enzymes within the 1-carbon pathway have been shown to affect S-adenosyl methionine (SAM) production, which is the sole methyl donor in the cell. Allelic variants of several enzymes within this pathway have been associated with altered SAM levels either directly, or indirectly as reflected by altered levels of SAH and Homocysteine levels, and altered levels of DNA methylation. We, therefore, asked whether the five most commonly occurring polymorphisms in four of the enzymes in the 1-carbon pathway associated with CT gene expression status in patients with NSCLC.

Methods

Fifty patients among a cohort of 763 with NSCLC were selected based on CT gene expression status and typed for five polymorphisms in four genes known to affect SAM generation by allele specific q-PCR and RFLP.

Results

We identified a significant association between CT gene expression and the MTHFR 677 CC genotype, as well as the C allele of the SNP, in this cohort of patients. Multivariate analysis revealed that the genotype and allele strongly associate with CT gene expression, independent of potential confounders.

Conclusions

Although CT gene expression is associated with DNA demethylation, in NSCLC, our data suggests this is unlikely to be the result of decreased MTHFR function.

【 授权许可】

   
2013 Senses et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Caballero OL, Chen YT: Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer science 2009, 100(11):2014-2021.
• [2]Loriot A, Reister S, Parvizi GK, Lysy PA, De Smet C: DNA methylation-associated repression of cancer-germline genes in human embryonic and adult stem cells. Stem cells (Dayton, Ohio) 2009, 27(4):822-824.
• [3]Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, Loukinov DI, Pugacheva E, Hong JA, Morse H 3rd, Schrump DS, et al.: Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res 2005, 65(17):7751-7762.
• [4]Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR, Adnani MT, Loukinov DI, Vatolin S, Risinger JI, et al.: Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res 2005, 65(17):7763-7774.
• [5]Gure AO, Wei IJ, Old LJ, Chen YT: The SSX gene family: characterization of 9 complete genes. International journal of cancer 2002, 101(5):448-453.
• [6]Jager E, Knuth A: The discovery of cancer/testis antigens by autologous typing with T cell clones and the evolution of cancer vaccines. Cancer Immun 2012, 12:6.
• [7]Castro R, Rivera I, Ravasco P, Camilo ME, Jakobs C, Blom HJ, de Almeida IT: 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C–>T and 1298A–>C mutations are associated with DNA hypomethylation. J Med Genet 2004, 41(6):454-458.
• [8]Friso S, Girelli D, Trabetti E, Olivieri O, Guarini P, Pignatti PF, Corrocher R, Choi SW: The MTHFR 1298A>C polymorphism and genomic DNA methylation in human lymphocytes. Cancer Epidemiol Biomarkers Prev 2005, 14(4):938-943.
• [9]Olteanu H, Munson T, Banerjee R: Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002, 41(45):13378-13385.
• [10]Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP: A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Molecular genetics and metabolism 2000, 70(4):310-315.
• [11]Paz MF, Avila S, Fraga MF, Pollan M, Capella G, Peinado MA, Sanchez-Cespedes M, Herman JG, Esteller M: Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002, 62(15):4519-4524.
• [12]Cadieux B, Ching TT, Vandenberg SR, Costello JF: Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 2006, 66(17):8469-8476.
• [13]Woloszynska-Read A, Zhang W, Yu J, Link PA, Mhawech-Fauceglia P, Collamat G, Akers SN, Ostler KR, Godley LA, Odunsi K, et al.: Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Clin Cancer Res 2011, 17(8):2170-2180.
• [14]Gure AO, Chua R, Williamson B, Gonen M, Ferrera CA, Gnjatic S, Ritter G, Simpson AJ, Chen YT, Old LJ, et al.: Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res 2005, 11(22):8055-8062.
• [15]Gaunt TR, Rodriguez S, Day IN: Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC bioinformatics 2007, 8:428. BioMed Central Full Text
• [16]Radtke I, Mullighan CG, Ishii M, Su X, Cheng J, Ma J, Ganti R, Cai Z, Goorha S, Pounds SB, et al.: Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci USA 2009, 106(31):12944-12949.
• [17]R Core Team: R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. http://www.R-project.org/ webcite
• [18]Shen H, Spitz MR, Wang LE, Hong WK, Wei Q: Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 2001, 10(4):397-401.
• [19]Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR, Wei Q: Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenetics and genomics 2005, 15(8):547-555.
• [20]Suzuki T, Matsuo K, Hiraki A, Saito T, Sato S, Yatabe Y, Mitsudomi T, Hida T, Ueda R, Tajima K: Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis 2007, 28(8):1718-1725.
• [21]Hofmann O, Caballero OL, Stevenson BJ, Chen YT, Cohen T, Chua R, Maher CA, Panji S, Schaefer U, Kruger A, et al.: Genome-wide analysis of cancer/testis gene expression. Proc Natl Acad Sci USA 2008, 105(51):20422-20427.
• [22]Matthews RG, Daubner SC: Modulation of methylenetetrahydrofolate reductase activity by S-adenosylmethionine and by dihydrofolate and its polyglutamate analogues. Advances in enzyme regulation 1982, 20:123-131.
• [23]Song MR, Ghosh A: FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation. Nat Neurosci 2004, 7(3):229-235.
• [24]Chau CM, Lieberman PM: Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 2004, 78(22):12308-12319.
• [25]Huang J, Kent JR, Placek B, Whelan KA, Hollow CM, Zeng PY, Fraser NW, Berger SL: Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. J Virol 2006, 80(12):5740-5746.